ABSTRACT
The basis of disease is colorectal, genitourinary, or other infections of the genital area. FG is currently encountered in any age group. However, its prevalence increases after the age of 50 years. [2] The disease is 10-fold more prevalent in males than in females. The lower prevalence in females is suggested to be associated with the fact that the female perineum easily drains through the vagina, thereby possibly preventing the development of the disease. [3, 4] FG has a high mortality rate, despite standard therapies that involve aggressive large debridements and the use of broadspectrum antibiotics. [5] The following three factors have been advocated to influence disease outcomes: disease-, patient-, and physician-related factors. Physician-related factors include aggressive surgical intervention and appropriate anti-biotherapy selection. Parameters such as age, body temperature, heart rate, and respiratory rate are patient-related factors. The extent of disease is a disease-related factor. [6] ORIGINAL ARTICLE Ulus Travma Acil Cerrahi Derg, September 2017, Vol. 23, No. 5 
INTRODUCTION
Fournier's gangrene (FG) is a rare, necrotizing fasciitis of the perineal and genital area and is a life-threatening condition that requires emergency surgery. FG is rapidly progressive and leads to septic shock and death if not promptly treated.
No reliable tool for predicting FG severity is currently available; however, scoring systems can be used to accomplish this task. An ideal scoring system must simply provide clear and effective data regarding the patient and must also detect high complication and mortality rates. [5] In this regard, Laor et al. [7] described a FG severity index in 1995. Many authors have begun using this severity index. Approximately 15 years after that study, Yilmazlar et al. [6] developed the Uludag FGSI (UFGSI) by incorporating age and the extent of disease in the FGSI scoring system. Although other scoring systems have been discussed in the literature, FGSI and UFGSI are the two most widely accepted scoring systems. [5] This study aimed to evaluate the usefulness of FGSI and UFG-SI for predicting mortality in patients with FG.
MATERIALS AND METHODS
Patients with FG who were treated and followed up at two education and research hospitals with high patient load between January 2012 and December 2015 were retrospectively reviewed. Age, sex, comorbid conditions, number of comorbid conditions, length of hospital stay, number of debridements, whether ostomy was performed or not, bacterial growth in wound culture, types of isolated bacteria, presence of diabetes mellitus (DM), and FGSI and UFGSI values were recorded. The sensitivities of the FGSI and UFGSI scoring systems were evaluated for predicting mortality-related factors and disease prognosis. In addition, UFGSI parameters were separately evaluated. Patients were grouped as survivors (Group I) or non-survivors (Group II). Parameters and scores of FGSI and UFGSI scoring systems are shown in Table  1 (FGSI, A; UFGSI, A + B + C). [6] The parameters added to UFGSI were age (aged >60 years = 1 point, aged <60 years = 0 points) and extent of disease (FG confined to urogenital and/or anorectal area = 1 point, confined to pelvic area = 2 points, extended beyond pelvic area = 6 points).
Statistical Analysis
The data were statistically analyzed using IBM SPSS Statistics version 22 software package. Fisher's exact test was used to compare categorical data between the two groups. MannWhitney U test was used to compare the two groups if continuous variables showed non-parametric features. The optimum cutoff level of the power of the FGSI and UFGSI scoring systems for predicting mortality was calculated using an ROC analysis. ROC curves were created using IBM SPSS Statistics version 22 software package. AUC, sensitivity, specificity, positive likelihood ratio (LR), negative LR, positive predictive value (PV), negative PV, and confidence intervals for these values were calculated using the Med Calc demo version. A p value of <0.05 was considered to be statistically significant.
RESULTS
In total, 29 patients were included in this study. The mor- Fournier's gangrene confined to the urogenital and/or anorectal region, add "1"
Fournier's gangrene confined to the pelvic region, add "2"
Fournier's gangrene extending beyond the pelvic region, add "6" c. Age score Age ≥60 years, add "1" Age <60 years, add "0" Uludag Fournier's gangrene severity index = a+b+c tality rate was 20.6% (six patients). Of all the patients, 11 (37.9%) were females and 18 (62.1%) were males. The mean age was 51.52±13.36 (range, 29-78) years. According to sex, the average age was 49 years for females and 53 years for males. There was no significant difference between the groups in terms of age and sex (p>0.05). Bacterial growth was observed in wound cultures of 17 patients (58.6%). Of all patients with bacterial growth, 11 (47.8%) were in Group I and six (100%) were in Group II. The most commonly encountered bacteria was Escherichia coli, which was present in 10 patients (58.8%), followed by Acinetobacter in two patients (11.8%) and Streptococcus, Staphylococcus aureus, Pseudomonas, Klebsiella, and Citrobacter each occurring in one patient (5.9%). The presence of bacterial growth in the cultures was significantly different between the two groups (p<0.05). Fourteen patients (48.3%) had comorbid conditions. The mean number of comorbid conditions was 0.83±1.03 in Group I, 2.00±1.41 in Group II, and 1.07±1.19 in the whole study group. There was a significant difference between the groups in terms of the total number of comorbid conditions (p<0.05) ( Table 2 ). The presence of DM, number of debridements, length of hospital stay, and other variables did not significantly differ between the two groups (p>0.05).
In the analysis of the FGSI and UFGSI scoring systems, FGSI and UFGSI scores were significantly higher in Group II than in Group I (p<0.05) ( Table 1 ).
The extent of disease, body temperature, pulse rate, and HCO3 values were significantly higher in Group II than in Group I (p<0.05). The other variables did not significantly differ between the two groups ( Table 3 ). The FGSI and UFGSI had 100% sensitivity and 78.2% and 73.9% specificity, respectively, for predicting mortality. ROC curves that were drawn Table 4 and Figure 1 .
DISCUSSION
FG is a rapidly progressive, infective, necrotizing fasciitis that is characterized by thrombosis and necrosis of subcutaneous tissues and superficial vessels in the perineal, genital, or perianal area. [8] The mortality rate is as high as 7.5%-40%, despite advances in medicine and technology. [8] [9] [10] The mortality rate was reported to be 7.5% by Sorensen et al. [11] and 16% by Eke et al. [3] in a review of 1726 patients. The mortality rate was 20.6% in this study, which was consistent with that reported in the literature. Many factors have been reported to influence mortality. Female sex has been advocated to be a risk factor for high mortality rates. [4, 12] In this study, FG resulted in the death of 27% of females and 16.6% of males, showing higher mortality rate in females. Consistent with other studies, sex did not affect mortality. [4, 13] Age is another concern that is discussed as a factor that affects mortality. [5, 14, 15] The present study did not report any association between age and mortality, similar to that reported by Marin et al. [14] Ulus Travma Acil Cerrahi Derg, September 2017, Vol. 23, No. 5
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Üreyen et al. Usefulness of FGSI and UFGSI scoring systems for predicting mortality in patients with Fournier' s gangrene Many other studies have investigated the role of comorbid conditions in mortality. In this regard, very few parameters have been suggested to have a significant role. [5, 14] As one of the factors discussed, DM was present in nine patients (31%) in this study. Of the patients who died, 50% had DM in Group II and 26.1% had DM in Group I. Although the prevalence of DM was high in the high mortality group, as observed in other studies, DM had no effect on mortality. [5, 6, 14] In the current study, although the presence of comorbid conditions did not affect mortality alone, the presence of more than one comorbid conditions significantly affected mortality. Among these comorbid conditions, malignancy was reported to be an independent risk factor for mortality. [12] However, in our patients, only one patient was diagnosed as having malignancy, and this patient case was in Group I.
FGSI was developed by Laor et al., [7] who used vital findings and some laboratory data to determine the severity and prognosis of FG in patients. In this scoring system, the mortality rate is 75% if FGSI is >9 points and the survival rate is 78% if FGSI is <9 points. However, Yilmazlar et al., [6] who asserted that this classification has some drawbacks, added a dissemination score and age into this system to create a modified UFGSI scoring system. Different studies have compared the two classification systems and evaluated their strengths. [5, 14] The present study evaluated the roles of these scoring systems for predicting mortality. Both scoring systems were found to be correlated to mortality. Both systems yielded 100% sensitivity in the analysis of sensitivity and specificity. The specificity was 78% for FGSI and 73% for UFGSI. Yilmazlar et al. [6] described the UFGSI scoring system and reported a sensitivity of 94% and specificity of 81% for UFGSI. Roghmann et al. [5] reported these figures to be 85% and 67% for UFGSI. In the abovementioned two studies, the sensitivity and specificity for FGSI were 65%-100% and 88%-67% , respectively. Czymek et al. [4] reported a sensitivity of 87% and a specificity of 77% for FGSI, whereas Laor et al. [7] reported a sensitivity of 75% and specificity of 78%. In another study by Yılmazlar et al., [13] no survivor was reported among patients with UFGSI scores of ≥9 in a series of 120 cases. The cutoff values for FGSI and UFGSI were 7 and 9, respectively. Six of 12 cases with a score of >7 for FGSI died, whereas six of 13 cases with a score of >9 for UFGSI died. Despite these high rates, we consider that lower mortality in these cases was associated with a prompt and effective treatment.
The present study evaluated the association with mortality using common parameters in the two scoring systems, and age and the extent of disease that are only included in UFGSI. Of the common parameters, heart rate, body temperature, and bicarbonates were significant. Serum creatinine, hematocrit, and potassium levels were related to mortality in some studies. [10, 14] Roghmann et al. [5] reported an association between mortality and creatinine and hematocrit. As observed, all parameters included in FGSI and UFGSI were significant. Therefore, the authors have begun evaluating different parameters such as albumin, alkaline phosphatase, cholesterol, lactate dehydrogenase, platelet count, calcium, and magnesium. [16] [17] [18] However, the value of these parameters for predicting mortality is only hypothetical. In the present study, the parameters of age and the extent of disease different from FGSI in UFGSI were separately analyzed. Age was not related to mortality; however, the extent of disease was higher in Group II than in Group I. One study that explored the need to establish a new scoring system suggested the use of the extent of disease for predicting prognosis. [5] The treatment of FG is based on large debridement of the wound and drainage after removing necrotic tissues, using broad-spectrum antibiotics, and providing hemodynamic stability. [3, 8] All patients underwent large debridement under general anesthesia, and prophylactic broad-spectrum anti-biotherapy was initiated. Anti-biotherapy was revised according to the results of the cultures. In this study, bacterial growth was observed in wound cultures of 58.6% of patients. In addition, bacterial growth was observed in all fatalities. E. coli was the most prevalent agent in 58.8% of patients. The type of isolated bacteria and their rates were similar to those reported in the literature. [5, 8] The presence of bacterial growth in the culture was an important factor for mortality; this was independent of the bacteria type.
The extensiveness of debridement can be life-saving; however, the association between mortality and number of debridements remains debatable, [15] and many studies [14, 19, 20] found no association, similar to that observed in our study. The association between the presence of colostomy and mortality remains debatable. [14, 18, 19] Fourteen patients (48.3%) with FG in close proximity to the anal area and resulting in fecal contamination underwent fecal diversion to prevent infections, morbidity, and mortality. The study by Li et al. [18] advocated fecal diversion to reduce mortality. However, fecal diversion had no role in reducing mortality in our series, similar to the study by Ozturk et al. [19] We consider that fecal diversion must not be routinely performed in all patients but must only be performed in selected patients with a high risk for contamination owing to close proximity to the anal area.
Our study had some limitations. The study had a retrospective design and small sample size. However, there are no large series of patients with FG in the literature, and there are continuous case reports. [21] Conclusion FG must be considered for abscesses that occur in the perianal, perineal, and genital area that can lead to high mortality if left untreated, although the symptoms may appear insignificant. Patients must be treated with maximum care, and an aggressive treatment approach must be adopted. FGSI and UFGSI are useful for predicting mortality associated with FG. In this study, age had no influence in the UFGSI scoring system. We assume that age is not an important prognostic fac-tor, considering the fact that FG often occurs in advanced age groups. The extent of disease was an important prognostic parameter. Whichever scoring system is used, we suggest the use of the extent of disease score in UFGSI.
